Xeris Biopharma Holdings, Inc.
NASDAQ:XERSBiotechnology
+$0.04 today
- Market cap
- $3.04B
- Beta
- 0.90
- P/E (TTM)
- 98.7
- EPS (TTM)
- $0.07
Volume 2.56M
Average 1.66M
Dividends
Xeris Biopharma Holdings, Inc. dividends
Review the payout history, yield, and how well earnings and cash flow support the dividend.
Dividends
Dividend history, growth & yield
Yield
0.00%
Annual Div/Share
$0.00
Payout Ratio
0.0%
Frequency
—
Shareholder Yield
0.36%
Next Ex-Date
Not announced
Next Payment
—
Analysis
The current indicated dividend yield is 0.00%. The payout ratio is 0.0%, so compare payout growth against earnings coverage.
Competitor dividends
How does Xeris Biopharma Holdings, Inc. compare as an income stock?
Compare dividend yield, payout ratios, and buybacks with similar companies.
Competitor Dividends
Peer payout, dividend, and buyback comparison
| Company | Market Cap | Dividend Yield | Annual Dividend | Payout Ratio | Buyback Yield |
|---|---|---|---|---|---|
Ascendis Pharma A/S NASDAQ:ASND | $18.06B | 0.00% | $0.00 | 0.00% | 0.93% |
Corcept Therapeutics Incorporated NASDAQ:CORT | $7.98B | 0.00% | $0.00 | 0.00% | 1.35% |
MBX Biosciences, Inc. Common Stock NASDAQ:MBX | $2.78B | 0.00% | $0.00 | 0.00% | 0.00% |
Septerna Inc NASDAQ:SEPN | $2.03B | 0.00% | $0.00 | 0.00% | 0.00% |
Eton Pharmaceuticals, Inc. NASDAQ:ETON | $1.84B | 0.00% | $0.00 | 0.00% | 0.00% |
MannKind Corporation NASDAQ:MNKD | $1.33B | 0.00% | $0.00 | 0.00% | 0.00% |
GH Research PLC NASDAQ:GHRS | $1.31B | 0.00% | $0.00 | 0.00% | 0.00% |
Spruce Biosciences, Inc. NASDAQ:SPRB | $124.47M | 0.00% | $0.00 | 0.00% | 0.00% |
Questions
Dividend questions
Common questions about XERS's dividend, answered from reported figures.
Does XERS stock pay dividends?
Xeris Biopharma Holdings, Inc. (XERS) currently pays a dividend. The indicated dividend per share is 0.00 USD and the dividend yield is 0.00%.
Is XERS's dividend covered?
The payout ratio is 0.0%, so compare that against earnings and free cash flow before relying on the dividend.
Continue the stock analysis
Jump to another research area for this company.